{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:38:06Z","timestamp":1784129886463,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11596-014-1371-4","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T09:52:36Z","timestamp":1418032356000},"page":"902-906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement"],"prefix":"10.1007","volume":"34","author":[{"given":"Jian-tang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-feng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-min","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng-shan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,6]]},"reference":[{"issue":"10","key":"1371_CR1","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1161\/CIR.0b013e318214876d","volume":"123","author":"V Fuster","year":"2011","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, et al. 2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation, 2011,123(10): e269\u2013367","journal-title":"Circulation"},{"issue":"1","key":"1371_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.21.1.4","volume":"21","author":"P Petersen","year":"1990","unstructured":"Petersen P. Thromboembolic complications in atrial fibrillation. Stroke, 1990,21(1):4\u201313","journal-title":"Stroke"},{"issue":"3","key":"1371_CR3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2006.05.021","volume":"48","author":"RO Bonow","year":"2006","unstructured":"Bonow RO, Carabello BA, Chatterjee K, et al. ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol, 2006,48(3):e1\u2013e148","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1371_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1378\/chest.127.1.53","volume":"127","author":"D Hering","year":"2005","unstructured":"Hering D, Piper C, Bergemann R, et al. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German experience with low-intensity anticoagulation study. Chest, 2005,127(1): 53\u201359","journal-title":"Chest"},{"issue":"4","key":"1371_CR5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0003-4975(10)63816-7","volume":"44","author":"LH Edmunds Jr","year":"1987","unstructured":"Edmunds Jr LH. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg, 1987,44(4):430\u2013450","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"1371_CR6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jacc.2007.10.058","volume":"51","author":"A Russo","year":"2008","unstructured":"Russo A, Grigioni F, Avierinos JF, et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol, 2008,51(12):1203\u20131211","journal-title":"J Am Coll Cardiol"},{"issue":"9689","key":"1371_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","volume":"374","author":"JC1 Sun","year":"2009","unstructured":"Sun JC1, Davidson MJ, Lamy A, et al. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet, 2009,374(9689): 565\u2013576","journal-title":"Lancet"},{"issue":"12","key":"1371_CR8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146(12):857\u2013867","journal-title":"Ann Intern Med"},{"issue":"6","key":"1371_CR9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/01.STR.0000223048.70103.F1","volume":"37","author":"LB Goldstein","year":"2006","unstructured":"Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006,37(6):1583\u20131633","journal-title":"Stroke"},{"issue":"9","key":"1371_CR10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0002-9149(83)90673-2","volume":"51","author":"JH Chesebro","year":"1983","unstructured":"Chesebro JH, Fuster V, Elveback LR, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol, 1983,51(9):1537\u20131541","journal-title":"Am J Cardiol"},{"issue":"5","key":"1371_CR11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2125.2005.02361.x","volume":"59","author":"JH You","year":"2005","unstructured":"You JH, Chan FW, Wong RS, et al. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br J Clin Pharmacol, 2005,59(5):582\u2013587","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"1371_CR12","first-page":"758","volume":"11","author":"H Zhang","year":"2009","unstructured":"Zhang H, Chen XJ, Zhen RL, et al. Antithrombotic effect of warfarin with different anticoagulation intensities on prognosis of old patients with paroxysmal atrial fibrillation. Chin J Geriatr Heart Brain Vessel Dis (Chinese), 2009, 11(10):758\u2013761","journal-title":"Chin J Geriatr Heart Brain Vessel Dis (Chinese)"},{"issue":"4","key":"1371_CR13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjcard.2009.10.018","volume":"105","author":"J Menke","year":"2010","unstructured":"Menke J, L\u00fcthje L, Kastrup A, et al. Thromboembolism in atrial fibrillation. Am J Cardiol, 2010,105(4):502\u2013510","journal-title":"Am J Cardiol"},{"issue":"2","key":"1371_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jacc.2009.03.044","volume":"54","author":"DR Holmes Jr","year":"2009","unstructured":"Holmes DR Jr1, Kereiakes DJ, Kleiman NS, et al. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol, 2009,54(2):95\u2013109","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1371_CR15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/europace\/eur263","volume":"14","author":"JP Bassand","year":"2012","unstructured":"Bassand JP. Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents. Europace, 2012,14(3):312\u2013324","journal-title":"Europace"},{"issue":"8","key":"1371_CR16","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.96.8.2751","volume":"96","author":"CH Hennekens","year":"1997","unstructured":"Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 1997,96(8):2751\u20132753","journal-title":"Circulation"},{"issue":"9678","key":"1371_CR17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet, 2009,373(9678):1849\u20131860","journal-title":"Lancet"},{"issue":"6","key":"1371_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","volume":"150","author":"N Calonger","year":"2009","unstructured":"US Preventive Services Task Force. Calonger N, Petitti DB, et al. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 2009,150(6):396\u2013404","journal-title":"Ann Intern Med"},{"key":"1371_CR19","first-page":"CD003464","volume-title":"Cochrane Database Syst Rev","author":"DR Massel","year":"2013","unstructured":"Massel DR, Little SH. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev, 2013:CD003464. doi: 10.1002\/14651858.CD-003464.pub"},{"issue":"8","key":"1371_CR20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","volume":"329","author":"AG Turpie","year":"1993","unstructured":"Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med, 1993, 329(8):524\u2013529","journal-title":"N Engl J Med"},{"issue":"3Pt1","key":"1371_CR21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-8703(95)90365-8","volume":"130","author":"JC Cappelleri","year":"1995","unstructured":"Cappelleri JC, Fiore LD, Brophy MT, et al. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis. Am Heart J, 1995,130(3 Pt 1):547\u2013552","journal-title":"Am Heart J"},{"issue":"8","key":"1371_CR22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1525-1497.2004.30419.x","volume":"19","author":"RJ Larson","year":"2004","unstructured":"Larson RJ, Fisher ES. Should aspirin be continued in patients started on warfarin? J Gen Intern Med, 2004,19(8): 879\u2013886","journal-title":"J Gen Intern Med"},{"issue":"2","key":"1371_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","volume":"167","author":"F Dentali","year":"2007","unstructured":"Dentali F, Douketis JD, Lim W, et al. Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med, 2007,167(2):117\u2013124","journal-title":"Arch Intern Med"},{"issue":"2","key":"1371_CR24","first-page":"e164","volume":"55","author":"M Brtko","year":"2013","unstructured":"Brtko M, Dusek J. Antithrombotic therapy in patients after valve surgery with special attention to the combination of anticoagulant and antiplatelet therapy. Thrombosis, 2013,55(2):e164\u2013e169","journal-title":"Thrombosis"},{"issue":"1","key":"1371_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1067\/mhj.2001.116331","volume":"142","author":"SD Berkowitz","year":"2001","unstructured":"Berkowitz SD. Antithrombotic therapy after prosthetic cardiac valve implantation: potential novel antithrombotic therapies. Am Heart J, 2001,142(1):7\u201313","journal-title":"Am Heart J"},{"issue":"2","key":"1371_CR26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(00)01135-9","volume":"37","author":"D Massel","year":"2001","unstructured":"Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol, 2001,37(2):569\u2013578","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1371-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-014-1371-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1371-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:11:05Z","timestamp":1559394665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-014-1371-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1371"],"URL":"https:\/\/doi.org\/10.1007\/s11596-014-1371-4","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}